Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
May 05, 2020	8-K	Report of unscheduled material events or corporate event	View HTML 0001804220-20-000009.pdf 0001804220-20-000009.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 05, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001804220-20-000011.pdf 0001804220-20-000011.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 04, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000046.pdf 0001708138-20-000046.xls
Apr 24, 2020	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0000930413-20-001198.pdf 0000930413-20-001198.xls
Apr 24, 2020	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0000930413-20-001199.pdf 0000930413-20-001199.xls
Apr 24, 2020	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0000930413-20-001200.pdf 0000930413-20-001200.xls
Apr 20, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000042.pdf 0001708138-20-000042.xls
Apr 20, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000043.pdf 0001708138-20-000043.xls
Apr 20, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000044.pdf 0001708138-20-000044.xls
Apr 16, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000038.pdf 0001708138-20-000038.xls

Data provided by Kaleidoscope.

Investors & Media